for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

CMIC Holdings Co Ltd

2309.T

Latest Trade

1,887.00JPY

Change

38.00(+2.06%)

Volume

105,100

Today's Range

1,879.00

 - 

1,914.00

52 Week Range

1,505.00

 - 

2,211.00

As of on the Tokyo Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
1,849.00
Open
1,899.00
Volume
105,100
3M AVG Volume
1.09
Today's High
1,914.00
Today's Low
1,879.00
52 Week High
2,211.00
52 Week Low
1,505.00
Shares Out (MIL)
18.07
Market Cap (MIL)
35,708.77
Forward P/E
15.91
Dividend (Yield %)
1.70

Next Event

Q1 2020 CMIC Holdings Co Ltd Earnings Release

Latest Developments

More

CMIC Holdings completes share repurchase

CMIC Holdings buys back 48,000 shares for 111.2 mln yen

CMIC HOLDINGS buys back 52,500 shares for 120.1 mln yen in May

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About CMIC Holdings Co Ltd

CMIC HOLDINGS Co., Ltd. mainly provides pharmaceutical development support services. The Contract Research Organization (CRO) segment offers monitoring, data management, pharmaceutical consulting and nonclinical services. The Contract Manufacturing Organization (CMO) segment is engaged in the entrusted manufacture of drugs for pharmaceutical companies. The Contract Sales Organization (CSO) segment is engaged in the operation and marketing support for medicinal products. The Health Care segment conducts site support institute (SMO) business, and provides health care information services. The Intellectual Property Development (IPD) segment develops and sells diagnostic products and orphan drugs.

Industry

Major Drugs

Contact Info

22F, Hamamatsucho Bldg., 1-1-1, Shibaura

+81.3.67798000

https://www.cmicgroup.com/

Executive Leadership

Kazuo Nakamura

Chairman of the Executive Board, Chief Executive Officer, Representative Director

Keiko Ohishi

Executive President, Chief Operating Officer, Representative Director

Wataru Mochizuki

Chief Financial Officer, Senior Managing Executive Officer, Director

Yoshiyuki Hano

Chief Human Resource Officer, Senior Managing Executive Officer, Director

Hidetoshi Takeda

Executive Vice President, Chairman of Subsidiaries

Key Stats

3.00 mean rating - 1 analysts
Sell
Hold
Buy
Revenue (MM, JPY)

2017

0.1K

2018

0.1K

2019

0.1K

2020(E)

0.1K
EPS (JPY)

2017

82.900

2018

79.710

2019

98.930

2020(E)

116.200
Price To Earnings (TTM)
19.23
Price To Sales (TTM)
0.48
Price To Book (MRQ)
1.53
Price To Cash Flow (TTM)
6.39
Total Debt To Equity (MRQ)
86.24
LT Debt To Equity (MRQ)
51.02
Return on Investment (TTM)
3.65
Return on Equity (TTM)
2.10

Latest News

Latest News

BRIEF-Median Technologies And CMIC Holdings Announce Agreement To Provide Oncology Clinical Trial Services In Asia

* MEDIAN TECHNOLOGIES AND CMIC HOLDINGS CO., LTD. ANNOUNCE AGREEMENT TO PROVIDE COMPREHENSIVE CLINICAL TRIAL SERVICES

BRIEF-CMIC Holdings says integration of CRO business in consolidated subsidiaries

* Says co resolved to reorganize the CRO business and integrate co's wholly owned subsidiaries CMIC Co., Ltd. and CMIC-PMS Co., Ltd. on Oct. 1

BRIEF-CMIC Holdings says change of president

* Says it names Keiko Oishi-Nakamura as president, effective April 1

BRIEF-CMIC HOLDINGS to buy back 2.94 pct stake of shares

* Says it plans to repurchase up to 550,000 shares (2.94 percent stake) for up to 1 billion yen, during the period from Dec. 26 to July 20, 2018

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up